drugset / Trial / NCT01615991

Multicentre Canadian Study to Measure the Safety and Efficacy of Radiosynoviorthesis

NCT01615991 ↗

NaSingle-groupOpen-labelTreatment

Summary

Radiation synovectomy by intra-articular injection of beta-emitting radionuclides is considered a reliable and easy-to-perform therapy without harmful side-effects for the treatment of inflammatory joint disease in many countries. The goal of this study is to demonstrate Yttrium-90 citrate colloid or Rhenium-186 sulfide synovectomy are appropriate therapeutic interventions in patients with persistent active synovitis of a joint (characterized by pain, tenderness, and effusion) which is resistant to systemic therapy and intra-articular corticosteroid injections. The primary objective will be to assess the safety of an intra-articular administration of Yttrium-90 citrate colloid or Rhenium-186 sulfide. The secondary objective will be to assess the efficacy on synovitis.

Timeline

Start
2012-05-31
Primary completion
2017-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Rhenium-186 sulfide Unknown — Other
Subject Yttrium-90 citrate colloid Unknown 111 mbq Other
Subject Yttrium-90 citrate colloid Unknown 222 mbq Other